Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients: The younger, the better.

ABSTRACT:

SUBMITTER: Zhu L 

PROVIDER: S-EPMC11745850 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature